Search

everythinglearnresearchcommunity

for

Search:↓

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Blocking interferon-gamma might help treat various autoimmune diseases.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Certain gene variations increase the risk of alopecia areata in Koreans.

Researchers found four key proteins that affect the development of a specific hair type in Yangtze River Delta white goats.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Androgens can both increase body hair and cause scalp hair loss.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.